• Superoxide Dismutase Activity Assay Kit: Precision in Oxidat

  2026-05-27

  Unlock rapid, quantitative SOD activity assessment across diverse models with the Superoxide Dismutase Activity Assay Kit. Optimized for sensitivity and workflow integration, this APExBIO solution empowers reliable oxidative stress research while addressing interference challenges highlighted by recent mitochondrial ROS studies.

• Fosinopril’s Dual Elimination: Pharmacokinetic Innovation in

  2026-05-27

  The reference study delineates how fosinopril sodium, a third-generation ACE inhibitor, achieves unique pharmacokinetic and pharmacodynamic properties through dual renal and hepatic elimination. These findings have direct implications for hypertension research, especially in patient populations with renal impairment, and expand translational possibilities for cardiovascular disease models.

• Structural Insights and Affinity Tuning of CD38 CAR Binders

  2026-05-26

  This article examines the structural dissection and rational affinity optimization of CD38-targeting CAR binders, as reported by Cheng et al. The study's innovative approach reveals mechanisms for balancing CAR specificity, enzymatic inhibition, and minimizing off-tumor effects, providing a foundation for safer, more selective CAR-T therapies in hematologic malignancies.

• a-MSH, amide: Molecular Benchmarks for Pigmentation Research

  2026-05-26

  a-MSH, amide is a synthetic alpha-melanocyte-stimulating hormone amide, enabling precise modulation of pigmentation and inflammation in cellular models. This article details its mechanistic action, experimental benchmarks, and integration into pigmentation regulation research. It clarifies applications, limitations, and common misconceptions for reproducibility.

• In Vitro Efficacy of Temafloxacin Against Gram-Negative Path

  2026-05-25

  This article reviews the pivotal study assessing temafloxacin’s in vitro activity against a broad spectrum of Gram-negative bacteria. Key findings demonstrate temafloxacin’s robust potency against respiratory and enteric pathogens, with MIC values competitive with or superior to leading fluoroquinolones, informing its use in antibacterial research and intracellular pathogen models.

• Fucoidan in Cancer Research: Protocols, Applications, and Tr

  2026-05-25

  Harness the full translational potential of Fucoidan, a high-purity sulfated α-L-fucan from APExBIO, with actionable workflows for apoptosis induction and immune modulation. This article bridges cutting-edge mechanistic insights with hands-on guidance and real-world troubleshooting for oncology applications.

• Astrocytic GAT-3 Shapes Synaptic Transmission in Dentate Gyr

  2026-05-24

  This study elucidates a novel regulatory pathway in which astrocytic GAT-3 modulates synaptic transmission and memory formation in the dentate gyrus via calcium signaling. The findings highlight the essential role of astrocyte-neuron interactions in hippocampal cognitive functions and offer fresh perspectives for targeted research on synaptic plasticity and cognitive impairment.

• Cimetidine in Translational Research: Beyond H2 Antagonism

  2026-05-23

  This thought-leadership article examines Cimetidine’s unique role as a histamine-2 receptor antagonist and partial agonist, emphasizing its mechanistic nuances, antitumor potential, and strategic application in translational research. By integrating the latest high-throughput blood-brain barrier (BBB) models and referencing both foundational and recent studies, the article provides actionable guidance for leveraging Cimetidine’s properties in cancer and barrier research. It further contrasts Cimetidine’s pharmacology with conventional H2 antagonists, highlights workflow compatibility, and sets a forward-looking vision for H2 receptor modulation in preclinical pipelines.

• RAB31 Defines an ESCRT-Independent Exosome Biogenesis Pathwa

  2026-05-22

  This study uncovers RAB31 as a critical regulator of exosome biogenesis independent of the canonical ESCRT machinery. By elucidating the molecular mechanisms through which RAB31 coordinates ILV formation and MVE fate, it offers a new framework for understanding exosome production and cargo sorting, with implications for cell communication and disease.

• Acetylcholine Chloride: Precision Tools for Gut-Brain Resear

  2026-05-22

  Acetylcholine Chloride unlocks new depth for dissecting cholinergic signaling in translational neuroscience and microbiome research. With high solubility and purity, it supports robust, reproducible assays targeting the gut-brain axis and neuromuscular junctions—now central to breakthroughs in epilepsy research.

• Maridomycin’s Antibacterial Spectrum: Insights for Macrolide

  2026-05-21

  This article examines the pivotal findings of Kondo et al. on maridomycin, a novel macrolide antibiotic demonstrating robust in vitro and in vivo activity against Gram-positive and select Gram-negative bacteria. The study's nuanced insights into antibacterial spectra, resistance development, and comparative efficacy inform the design and interpretation of bacterial infection research using macrolide agents.

• Abiraterone Acetate: CYP17 Inhibitor for Prostate Cancer Res

  2026-05-21

  Abiraterone acetate is a potent and selective CYP17 inhibitor, widely used in advanced prostate cancer research. Its prodrug formulation enhances solubility for experimental workflows and enables effective androgen biosynthesis inhibition in preclinical models. Evidence from patient-derived 3D spheroid systems clarifies its mechanistic limits and optimal research applications.

• C19orf66 Suppresses JEV via -1 PRF and NS3 Protein Targeting

  2026-05-20

  This study identifies C19orf66, an interferon-stimulated gene product, as an inhibitor of Japanese encephalitis virus (JEV) replication through dual mechanisms: interference with -1 ribosomal frameshifting and lysosomal degradation of NS3 protein. These findings advance understanding of host antiviral responses and suggest C19orf66 as a promising lead for broad-spectrum antiviral strategies.

• Toremifene Citrate: Decoding SERM Selectivity for Research

  2026-05-20

  Explore how Toremifene Citrate, a leading oral selective estrogen receptor modulator, enables precise interrogation of estrogen receptor signaling in breast cancer research. This article uniquely dissects the molecular basis of SERM selectivity and practical assay optimization.

• GPNMB-Based Multimodal Model Predicts ESCC Immunotherapy Res

  2026-05-19

  This study identifies circulating GPNMB as a predictive biomarker of immunotherapy response in esophageal squamous cell carcinoma (ESCC) and develops a clinically scalable multimodal model integrating tumor-immune crosstalk. The findings offer a framework for better patient stratification and rational immunotherapy selection in ESCC.

11587 records 1/773 page Next 12345 下5页 Last page